Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis
Yvonne Begus-Nahrmann, … , André Lechel, K. Lenhard Rudolph
Yvonne Begus-Nahrmann, … , André Lechel, K. Lenhard Rudolph
Published May 24, 2012
Citation Information: J Clin Invest. ;122(6):2283-2288. https://doi.org/10.1172/JCI61745.
View: Text | PDF | Corrigendum
Brief Report Article has an altmetric score of 2

Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis

  • Text
  • PDF
Abstract

Telomere shortening limits the proliferative capacity of a cell, but perhaps surprisingly, shortening is also known to be associated with increased rates of tumor initiation. A current hypothesis suggests that telomere dysfunction increases tumor initiation by induction of chromosomal instability, but that initiated tumors need to reactivate telomerase for genome stabilization and tumor progression. This concept has not been tested in vivo, since appropriate mouse models were lacking. Here, we analyzed hepatocarcinogenesis in a mouse model of inducible telomere dysfunction on a telomerase-proficient background, in telomerase knockout mice with chronic telomere dysfunction (G3 mTerc–/–), and in WT mice with functional telomeres and telomerase. Transient or chronic telomere dysfunction enhanced the rates of chromosomal aberrations during hepatocarcinogenesis, but only telomerase-proficient mice exhibited significantly increased rates of macroscopic tumor formation in response to telomere dysfunction. In contrast, telomere dysfunction resulted in pronounced accumulation of DNA damage, cell-cycle arrest, and apoptosis in telomerase-deficient liver tumors. Together, these data provide in vivo evidence that transient telomere dysfunction during early or late stages of tumorigenesis promotes chromosomal instability and carcinogenesis in telomerase-proficient mice.

Authors

Yvonne Begus-Nahrmann, Daniel Hartmann, Johann Kraus, Parisa Eshraghi, Annika Scheffold, Melanie Grieb, Volker Rasche, Peter Schirmacher, Han-Wong Lee, Hans A. Kestler, André Lechel, K. Lenhard Rudolph

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2009 Total
Citations: 1 1 2 1 2 2 1 2 1 1 1 1 5 3 1 25
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (25)

Title and authors Publication Year
miR-23a-mediated TRF2 repression in CD4 T cells from PLWH.
Nguyen LNT, Zhao J, Pyburn JS, Wang L, Schank M, Banik P, Hill AC, Wu XY, Zhang Y, Ning S, El Gazzar M, Moorman JP, Yao ZQ
Molecular immunology 2025
Putative Molecular Mechanisms Underpinning the Inverse Roles of Mitochondrial Respiration and Heme Function in Lung Cancer and Alzheimer’s Disease
Afsar A, Zhang L
Biology 2024
Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention
de Bardet JC, Cardentey CR, González BL, Patrone D, Mulet IL, Siniscalco D, Robinson-Agramonte MD
Bio/Technology 2023
Telomeres: Dysfunction, Maintenance, Aging and Cancer.
Liao P, Yan B, Wang C, Lei P
Aging and disease 2023
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker
V Sahm, C Maurer, T Baumeister, A Anand, J Strangmann, R Schmid, T Wang, M Quante
Oncotarget 2022
Telomeres: history, health, and hallmarks of aging
D Chakravarti, KA LaBella, RA DePinho
Cell 2021
Molecular Genetics in Neuroblastoma Prognosis
M Lerone, M Ognibene, A Pezzolo, G Martucciello, F Zara, M Morini, K Mazzocco
Children 2021
Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish
K Lex, MM Gil, B Lopes-Bastos, M Figueira, M Marzullo, K Giannetti, T Carvalho, MG Ferreira
Proceedings of the National Academy of Sciences 2020
Telomeres and Telomerase in the Development of Liver Cancer
L in der Stroth, U Tharehalli, C Günes, A Lechel
Cancers 2020
The role of telomeres and telomerase in cirrhosis and liver cancer
JC Nault, M Ningarhari, S Rebouissou, J Zucman-Rossi
Nature Reviews Gastroenterology & Hepatology 2019
Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture
R Olmer, L Engels, A Usman, S Menke, MN Malik, F Pessler, G Göhring, D Bornhorst, S Bolten, S Abdelilah-Seyfried, T Scheper, H Kempf, R Zweigerdt, U Martin
Stem Cell Reports 2018
Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice
I Ferrara-Romeo, P Martínez, MA Blasco, AJ Lustig
PloS one 2018
Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter
W Yu, X Qin, Y Jin, Y Li, C Santiskulvong, V Vu, G Zeng, Z Zhang, M Chow, J Rao
Oncotarget 2017
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients
R Ofner, C Ritter, B Heidenreich, R Kumar, S Ugurel, D Schrama, JC Becker
Journal of Cancer Research and Clinical Oncology 2016
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
CL Wilson, D Jurk, N Fullard, P Banks, A Page, S Luli, AM Elsharkawy, RG Gieling, JB Chakraborty, C Fox, C Richardson, K Callaghan, GE Blair, N Fox, A Lagnado, JF Passos, AJ Moore, GR Smith, DG Tiniakos, J Mann, F Oakley, DA Mann
Nature Communications 2015
The Presence of Telomere Fusion in Sporadic Colon Cancer Independently of Disease Stage, TP53/KRAS Mutation Status, Mean Telomere Length, and Telomerase Activity
H Tanaka, MJ Beam, K Caruana
Neoplasia (New York, N.Y.) 2014
Telomerase at the intersection of cancer and aging
BB de Jesus, MA Blasco
Trends in Genetics 2013
The Luminal Progenitor Compartment of the Normal Human Mammary Gland Constitutes a Unique Site of Telomere Dysfunction
N Kannan, N Huda, LR Tu, R Droumeva, G Aubert, E Chavez, RR Brinkman, P Lansdorp, J Emerman, S Abe, C Eaves, D Gilley
Stem Cell Reports 2013
Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target
J Pal, JS Gold, NC Munshi, MA Shammas
Translational Research 2013
Cause-specific telomere factors deregulation in hepatocellular carcinoma
ME Idrissi, V Hervieu, P Merle, F Mortreux, E Wattel
Journal of Experimental & Clinical Cancer Research 2013
Loss of telomere protection: consequences and opportunities
JJ Jacobs
Frontiers in Oncology 2013
Telomere stability and carcinogenesis: an off-again, on-again relationship
Jennifer Wanat, Brad Johnson
Journal of Clinical Investigation 2012
Telomere Profiling: Toward Glioblastoma Personalized Medicine
S Ferrandon, P Saultier, J Carras, P Battiston-Montagne, G Alphonse, M Beuve, C Malleval, J Honnorat, T Slatter, N Hung, J Royds, C Rodriguez-Lafrasse, D Poncet
Molecular Neurobiology 2012
Potential of telomerase activation in extending health span and longevity
BB de Jesus, MA Blasco
Current Opinion in Cell Biology 2012
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 3 X users
85 readers on Mendeley
See more details